帕瑞昔布钠对肝癌射频消融术患者全身炎性反应的影响  被引量:7

Effects of parecoxib on inflammatory response in patients after radio-frequency ablation for liver cancer

在线阅读下载全文

作  者:吕帅国[1] 李长生[1] 李廷坤[1] 汪蕾[1] 孙亚林[1] 卢锡华[1] 

机构地区:[1]河南省肿瘤医院麻醉科,郑州450003

出  处:《中国实用医刊》2015年第1期24-25,共2页Chinese Journal of Practical Medicine

摘  要:目的 评价帕瑞昔布钠对CT引导下经皮肝癌射频消融术患者术后炎性反应的影响.方法 择期行CT引导下经皮肝癌射频消融术的患者40例,性别不限,年龄45~68岁,体质量48 ~75 kg,ASA分级Ⅱ或Ⅲ级,肝功能Child-Pugh分级A级,采用随机数字表法将患者分为对照组(C组)和帕瑞昔布钠组(P组),每组20例.麻醉诱导:静脉注射异丙酚1~2 mg/kg和芬太尼2~4 μg/kg,插入喉罩后行机械通气.麻醉维持:吸入2%七氟醚,靶控输注瑞芬太尼,血浆靶浓度4 μg/L.术中维持BIS值45 ~60.P组于手术开始时静脉注射帕瑞昔布钠40 mg,C组给予等容量氯化钠注射液.分别于麻醉前、术后2h、24h和48 h时抽取上肢静脉血样,测定血浆肿瘤坏死因子-α(TNF-α)和白细胞介素-8(IL-8)的浓度.结果 与C组比较,P组术后2h、24 h和48 h时血浆TNF-α和IL-8的浓度降低(P<0.05).结论 帕瑞昔布钠可降低CT引导下经皮肝癌射频消融患者术后全身炎性反应。Objective To investigate the effects of parecoxib on inflammatory response in patients after CT-guided percutaneous radio-frequency ablation (RFA) for liver cancer.Methods Forty ASA Ⅱ or Ⅲ and Child-Pugh A patients of both sexes aged 45-68 years old,weighing 48-75 kg,undergoing CT-guided percutaneous radio-frequency ablation for liver cancer,were randomly divided into two groups (n =20 each):control group (group C) and parecoxib group (group P).Anesthesia was induced with propofol 1-2 mg/kg and fentanyl 2-4 pg/kg and maintained with inhalation of 2% sevoflurane and TCI remifentanil(Cp 4μg/L).Laryngeal mask airway was inserted,and the patients were mechanically ventilated.BIS value was maintained at 45-60.Blood samples were taken from veins of upper limb before surgery(T0) and at 2 h,24 h and 48 h after surgery(T1-3) for determination of plasma TNF-αand IL-8 concentrations.Results Compared with group C,plasma concentrations of TNF-α and IL-8 were significantly decreased at 2 h,24 h and 48 h after operation in group P(P 〈0.05).Conclusions Parecoxib can reduce the inflammatory response after CT-guided percutaneous radio-frequency ablation for liver cancer.

关 键 词:帕瑞昔布钠 炎症 导管消融术 肝肿瘤 

分 类 号:R927.2[医药卫生—药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象